Genome Research Trading Limited
10058101
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 07/05/2019
director · Since 24/01/2025
CHIEF OPERATING OFFICER
BRITISH · ENGLAND · Age 60
Also on 2 other boards
Persons with Significant Control
Genome Research Limited
Gibbs Building, 215 Euston Road, London, NW1 2BE
Reg: 2742969 · England And Wales · Company Limited By Guarantee
Notified 08/04/2016
CompanyRankvs 39309+ SIC 74909 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Turnover
£2.1M
Annual revenue
Net Worth
£1
Balance sheet strength
Cash
£232k
Cash in the bank
Profit Before Tax
£92k
Bottom line earnings
Net Current Assets
£1
Working capital
Current Assets
£517k
Current Liabilities
£517k
Debtors
£285k
Cost of Sales
£747k
Gross Profit
£1.3M
Admin Expenses
£1.2M
Operating Profit
£92k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 1.00 |
| 2025 | 1.00 |
Derived from filed accounts. Not audited figures.